Two new compounds may be able to treat retinitis pigmentosa, a group of inherited eye diseases that cause blindness. The compounds were identified using a virtual screening approach.
Chris McCausland has opened up about why he doesn’t use a white cane to help him navigate the world while blind. The Strictly ...
GlobalData on MSN14d
FDA gives RMAT designation to Beacon’s retinitis pigmentosa treatmentThe FDA has granted RMAT designation to Beacon Therapeutics’ gene therapy, laru-zova, for treating X-linked retinitis ...
In this Healio Video Perspective from Retina 2025, Allen C. Ho, MD, discusses the growing promise of optogenetic therapy in treating patients with retinal disease.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback